HomeKALV • NASDAQ
add
Kalvista Pharmaceuticals Inc
Previous close
$11.09
Day range
$10.55 - $11.36
Year range
$7.30 - $15.50
Market cap
562.78M USD
Avg Volume
640.19K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jan 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 30.35M | 185.53% |
Net income | -48.51M | -67.11% |
Net profit margin | — | — |
Earnings per share | -0.92 | -9.52% |
EBITDA | -42.71M | -29.65% |
Effective tax rate | -9.60% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jan 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 253.20M | 234.99% |
Total assets | 275.99M | 142.17% |
Total liabilities | 130.87M | 415.53% |
Total equity | 145.13M | — |
Shares outstanding | 49.72M | — |
Price to book | 3.78 | — |
Return on assets | -49.15% | — |
Return on capital | -73.75% | — |
Cash Flow
Net change in cash
| (USD) | Jan 2025info | Y/Y change |
|---|---|---|
Net income | -48.51M | -67.11% |
Cash from operations | -32.68M | -18.53% |
Cash from investing | 8.52M | 227.08% |
Cash from financing | 151.77M | 53,341.20% |
Net change in cash | 126.36M | 465.10% |
Free cash flow | -22.63M | -1.19% |
About
Founded
2004
Website
Employees
150
